V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009445 | 270005608 | 1.84 | 62.7 | Curative (C) | 2013-07-04 | 2013-07-05 | Carboplatin AUC 2 - 5 | 2 | N | 270018538 | CETUXIMAB + RT |
| 270009446 | 270012773 | 1.77 | null | Palliative (P) | null | 2013-07-03 | GemCarbo Days 1+8 | null | null | 270018542 | CARBO + FLUOROURACIL |
| 270009447 | 270005609 | null | 76.4 | Palliative (P) | 2013-08-13 | 2013-08-19 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | N | 270018547 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009448 | 270005610 | 1.6 | 63 | Curative (C) | null | 2016-07-08 | CETUXIMAB + OXALIPLATIN + MDG | null | null | 270018560 | CETUXIMAB |
| 270009449 | 270012774 | 1.66 | 92.2 | Palliative (P) | null | 2017-11-05 | Bevacizumab + Cape + Oxali 21day | null | null | 270018577 | GEMCARBO |
| 270009450 | 270012774 | 1.71 | 77.5 | Palliative (P) | 2013-04-10 | 2013-04-25 | Bevacizumab 7.5mg/kg | 2 | N | 270018577 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009451 | 270017834 | 1.55 | 103 | Not known (9) | 2014-09-21 | 2014-10-07 | Carboplatin + Etoposide iv&po | N | N | 270018596 | CAPECITABINE + MITOMYCIN + RT |
| 270009452 | 270017834 | 1.62 | 47.9 | Neo-adjuvant (N) | 2014-05-27 | 2014-07-12 | IRINOTECAN + MDG + PANITUMUMAB | null | Y | 270018596 | CETUXIMAB + RT |
| 270009453 | 270005611 | null | 64.5 | Palliative (P) | 2013-10-09 | 2013-10-09 | GEMCITABINE + NAB PACLITAXEL | N | N | 270018603 | ENZALUTAMIDE |
| 270009454 | 270005611 | null | 71.7 | Palliative (P) | 2013-07-17 | 2013-08-10 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 2 | Y | 270018603 | GEMCARBO |
| 270009455 | 270005612 | 1.62 | 59.7 | Palliative (P) | 2014-10-23 | 2014-11-16 | Cetuximab 7 day (Cycle 1) | N | N | 270018606 | CARBOPLATIN |
| 270009456 | 270005612 | null | 119.85 | Disease modification (D) | 2014-03-27 | 2014-04-02 | GemCarbo Days 1+8 | N | null | 270018606 | CARBOPLATIN + ETOPOSIDE |
| 270009457 | 270016001 | null | 40 | Adjuvant (A) | 2014-09-09 | 2014-09-09 | SCOT TRIAL | N | N | 270018622 | RALTITREXED |
| 270009458 | 270016001 | 1.82 | null | Palliative (P) | 2016-07-15 | 2016-07-17 | CETUXIMAB + IRINOTECAN + MDG | null | N | 270018622 | CETUXIMAB + IRINOTECAN + MDG |
| 270009459 | 270018881 | null | null | Adjuvant (A) | 2014-07-21 | 2014-08-06 | Bevacizumab + Cape + Oxali 14day | N | N | 270018644 | CETUXIMAB |
| 270009460 | 270018881 | 1.94 | 85 | Curative (C) | 2015-10-10 | 2015-10-18 | Capecitabine (14 days)+Carboplatin | N | Y | 270018644 | CISPLATIN + VINORELBINE + RT |
| 270009461 | 270018881 | null | 69.4 | Curative (C) | 2014-09-12 | 2014-09-13 | CAP + RT | N | N | 270018644 | CARBOPLATIN + RT |
| 270009462 | 270020007 | 1.88 | 65.3 | Curative (C) | 2016-08-10 | 2016-09-01 | CAP + RT | N | N | 270018685 | CETUXIMAB + RT |
| 270009463 | 270020007 | 1.77 | 71.2 | Palliative (P) | 2016-11-05 | 2016-11-06 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 270018685 | BEVACIZUMAB + CAPECITABINE |
| 270009464 | 270020182 | null | 65 | Curative (C) | 2013-05-22 | 2013-06-05 | Carboplatin + Etoposide iv&po | N | N | 270018695 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009465 | 270020182 | 1.6 | 52.1 | Palliative (P) | 2018-02-14 | 2018-02-15 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270018695 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009466 | 270020182 | 1.73 | 106.7 | Palliative (P) | 2017-10-15 | 2017-10-15 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 270018695 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009467 | 270005613 | 1.76 | null | Palliative (P) | 2016-06-09 | 2016-06-09 | Cetuximab + FOLFIRI cycle1 | N | N | 270018705 | CAPECITABINE + IRINOTECAN |
| 270009468 | 270005614 | null | 55.6 | Palliative (P) | 2015-05-24 | 2015-05-24 | Mitomycin Intravesical | null | null | 270018706 | FLUOROURACIL + MITOMYCIN |
| 270009469 | 270005615 | 1.68 | 86.3 | Neo-adjuvant (N) | null | 2014-12-05 | Cetuximab 7 day (Cycle 1) | null | null | 270018708 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009470 | 270005615 | 1.6 | 86.55 | Palliative (P) | 2016-10-25 | 2016-10-25 | Cetuximab 7 day (Cycle 1) | N | N | 270018708 | CAPECITABINE + CARBOPLATIN |
| 270009471 | 270005615 | 1.71 | 78.9 | null | 2014-02-22 | 2014-03-06 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270018708 | CAPECITABINE + IRINOTECAN |
| 270009472 | 270005616 | 1.75 | 112.3 | Curative (C) | 2016-02-02 | 2016-02-02 | Carboplatin AUC 2 - 5 | 02 | N | 270018717 | CAPECITABINE + IRINOTECAN |
| 270009473 | 270005617 | 1.7 | 107.3 | Curative (C) | 2015-02-19 | 2015-02-19 | Cetuximab 7 day (Cycle 1) | 02 | N | 270018737 | ENZALUTAMIDE |
| 270009474 | 270005618 | null | 54.9 | Adjuvant (A) | 2014-11-29 | 2014-11-30 | CISPLATIN + VINORELBINE | N | N | 270018755 | CARBOPLATIN |
| 270009475 | 270005618 | 1.81 | 52 | Neo-adjuvant (N) | 2015-06-10 | 2015-06-17 | Bevacizumab + Cape + Oxali 21day | 02 | N | 270018755 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009476 | 270005619 | 1.85 | 64.5 | Palliative (P) | 2016-04-11 | 2016-04-25 | CARBOPLATIN + VINORELBINE | 01 | N | 270018761 | CETUXIMAB + IRINOTECAN + MDG |
| 270009477 | 270005620 | 1.27 | 88 | Palliative (P) | 2015-12-05 | 2015-12-12 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | null | 270018764 | CARBOPLATIN + ETOPOSIDE |
| 270009478 | 270005620 | 1.69 | 73.5 | Palliative (P) | 2015-04-07 | 2015-04-13 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270018764 | IRINOTECAN |
| 270009479 | 270005621 | 1.82 | 87.5 | Palliative (P) | 2013-05-11 | 2013-05-11 | FOXTROT TRIAL | 02 | N | 270018778 | BCG |
| 270009480 | 270005621 | 1.55 | 77 | Adjuvant (A) | 2014-06-28 | 2014-07-11 | Enzalutamide | 2 | N | 270018778 | CVD |
| 270009481 | 270005621 | 1.75 | 104.5 | Not known (9) | 2016-01-20 | 2016-01-21 | CETUXIMAB + RT | 02 | N | 270018778 | CETUXIMAB |
| 270009482 | 270005622 | 1.78 | 70.6 | Neo-adjuvant (N) | 2015-08-11 | 2015-08-26 | Imatinib 400mg | N | N | 270018793 | CARBOPLATIN |
| 270009483 | 270012781 | 1.8 | 42 | Neo-adjuvant (N) | 2015-08-09 | 2015-08-11 | CISPLATIN + VINORELBINE + RT | 02 | N | 270018795 | CARBOPLATIN |
| 270009484 | 270012781 | 1.6 | 79.6 | Curative (C) | 2015-12-10 | 2015-12-24 | Cetuximab 14 day | N | N | 270018795 | FOXTROT TRIAL |
| 270009485 | 270005623 | 1.84 | 25.6 | Curative (C) | 2017-05-04 | 2017-05-10 | CARBOPLATIN + RT | 02 | null | 270018818 | FLUOROURACIL + RT |
| 270009486 | 270005623 | null | 0 | Adjuvant (A) | 2016-07-22 | 2016-08-02 | Trifluridine + Tipiracil | 2 | N | 270018818 | CHLORAMBUCIL |
| 270009487 | 270005623 | 1.78 | null | Curative (C) | 2013-04-14 | 2013-04-18 | Cetuximab 7 day (Cycle 1) | N | N | 270018818 | CETUXIMAB + RT |
| 270009488 | 270005624 | 1.65 | 0 | Neo-adjuvant (N) | 2013-09-18 | 2013-09-18 | Trastuzumab 21 day maintenance | 02 | N | 270018831 | CETUXIMAB |
| 270009489 | 270005625 | null | 59.2 | null | 2015-12-12 | 2015-12-23 | CARBOPLATIN + RT | N | N | 270018832 | GEMCARBO |
| 270009490 | 270005625 | 1.74 | null | Curative (C) | 2016-07-13 | 2016-07-15 | ChIVPP/EVA | N | N | 270018832 | CHOP |
| 270009491 | 270005626 | 1.67 | 0 | Palliative (P) | 2016-11-29 | 2016-12-03 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | null | 270018834 | CETUXIMAB + IRINOTECAN + MDG |
| 270009492 | 270005626 | 1.69 | 78.4 | null | 2017-11-20 | 2017-11-25 | Docetaxel 100mg/m2 (21 day) | N | N | 270018834 | FLUOROURACIL + RT |
| 270009493 | 270016006 | 1.63 | 60 | Neo-adjuvant (N) | 2014-06-09 | 2014-06-09 | Bevacizumab 10mg/kg | 02 | N | 270018839 | CARBOPLATIN + RT |
| 270009494 | 270016006 | 1.63 | 47.1 | Curative (C) | 2015-08-18 | 2015-09-13 | CAPECITABINE + OXALIPLATIN + RT | N | Y | 270018839 | CETUXIMAB |